Site search

Possible new drug for Crohn’s disease Research study

We aimed to determine the safety and effectiveness of a new study medication, guselkumab, for people with Crohn's disease

Etrasimod for the treatment of ulcerative colitis Research study

A clinical trial to assess the safety and efficacy of an oral medication called Etrasimod for moderately active ulcerative colitis (UC).

KBL697 for the treatment of ulcerative colitis Research study

Study investigated Lactobacillus gasseri in patients with mild to moderate active ulcerative colitis.

Sodium selenate for probable behavioural variant frontotemporal dementia Research study

A trial to test sodium selenate as a disease-modifying treatment for probable behavioural variant frontotemporal dementia (bvFTD).

Road traumas on the rise in warmer weather News article

Data collected by the Royal Melbourne Hospital (RMH) trauma team shows an increase in motor vehicle collision presentations throughout the spring and summer months.

Novel treatment for non-alcoholic fatty liver disease Research study

A trial to test the effectiveness of a novel non-invasive treatment for fatty liver disease.

Geographic atrophy from age-related macular degeneration Research study

The Golden trial is a study of a potential new treatment referred to as ISIS 696844 to determine its safety and effectiveness in slowing the progression of geographic atrophy (GA) caused by age-related macular degeneration (AMD).

OPT-302 with ranibizumab for neovascular age-related macular degeneration Research study

The ShORe trial aims to determine if the investigational medication OPT-302 will improve vision for people with wet age-related macular degeneration (AMD) when given in combination with ranibizumab, compared to ranibizumab alone.

The RMH Scrub Choir launches holiday disco special News article

The Royal Melbourne Hospital’s (RMH) Scrub Choir has launched its disco holiday special.

Freedom of Information (FOI)

Patients and their representatives have the right to access patient medical records held by the Royal Melbourne Hospital under the Freedom of Information Act.

I need cultural support

When you are admitted to the hospital, you should let us know if you have any specific cultural requirements.

Possible treatment for Parkinson’s disease Research study

Cerevel Therapeutics has begun a study of an experimental drug called CVL-751 as a possible treatment for people with Parkinson’s disease. 

Experimental treatment for Parkinson’s disease Research study

This is a study of an experimental treatment (referred to as “study drug”) called CVL-751 as a possible treatment for Parkinson’s disease.

Contact VTP

Find out the main contact and location information for the Victorian Tuberculosis Program.

Contact MDU

Find out the main contact and location information for Metabolic Diseases.

Contact Trauma Service

Find out the main contact and location information for the Major Trauma Service.

Contact ICU

Find out the main contact and location information for ICU.

Contact Emergency

The RMH Emergency is located at the RMH Parkville. Find out more about the RMH Emergency contact and location details.

Contact Cardiology

The RMH Cardiology is located at the RMH Parkville. Find out more about the RMH Cardiology contact and location details.

Five years on the road: Mobile Stroke Unit treats more than 2,700 patients News article

The first of its kind to hit the road in Australia, Melbourne’s highly successful Mobile Stroke Unit (MSU) has treated thousands of patients and changed the outcomes of so many Victorians.